Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Melike Belenli Gümüş
The Role of Real-World Evidence in CMS Price Negotiations
Cost-Effectiveness of IDegAsp in Diabetes Management: Insights from ARISE Study
Understanding the Cost and Clinical Impact of Multisystem Inflammatory Syndro...
The Economic Benefits of Preventive Health Programs
The Economic Burden of Knee Arthroplasty Revisions: A Cost Analysis from Türkiye
The Impact of Time Horizons on QALY Calculations in Healthcare
7
8
9
10
11
12